Cargando…
Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
OBJECTIVES: Evidence on the effects of the SARS-CoV-2 Omicron variant on vaccinated and unvaccinated pregnant women is sparse. This study aimed to compare maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy, according to their vaccine protection. METHOD...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859768/ https://www.ncbi.nlm.nih.gov/pubmed/36693525 http://dx.doi.org/10.1016/j.cmi.2023.01.013 |
_version_ | 1784874434249621504 |
---|---|
author | Corsi Decenti, Edoardo Salvatore, Michele Antonio Mandolini, Donatella Donati, Serena |
author_facet | Corsi Decenti, Edoardo Salvatore, Michele Antonio Mandolini, Donatella Donati, Serena |
author_sort | Corsi Decenti, Edoardo |
collection | PubMed |
description | OBJECTIVES: Evidence on the effects of the SARS-CoV-2 Omicron variant on vaccinated and unvaccinated pregnant women is sparse. This study aimed to compare maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy, according to their vaccine protection. METHODS: This national prospective cohort study enrolled pregnant women with a positive SARS-CoV-2 nasopharyngeal swab within 7 days of hospital admission between 1 January and 31 May, 2022. Women who received at least one dose of vaccine during pregnancy and those who completed the vaccine cycle with the first booster were considered protected against moderate or severe COVID-19 (MSCD). A multivariable logistic regression model evaluated the association between vaccine protection and disease severity. Maternal age, educational level, citizenship, area of birth, previous comorbidities, and obesity were analysed as potential risk factors. RESULTS: MSCD was rare (41/2147, 1.9%; 95% CI, 1.4–2.6), and the odds of developing it were significantly higher among unprotected women (OR, 2.78; 95% CI, 1.39–5.57). Compared with protected women (n = 1069), the unprotected (n = 1078) were more often younger, with lower educational degrees, and foreigners. A higher probability of MSCD was found among women with previous comorbidities (OR, 2.86; 95% CI, 1.34–6.12) and those born in Asian countries (OR, 3.05; 95% CI, 1.23–7.56). The percentage of preterm birth was higher among women with MSCD compared with milder cases (32.0% [8/25] versus 8.4% [161/1917], p < 0.001) as well as the percentage of caesarean section (52.0% [13/25] versus 31.6% [606/1919], p 0.029). DISCUSSION: Although severe maternal and perinatal outcomes were rare, their prevalence was significantly higher among women without vaccine protection. Vaccination during pregnancy has the potential to protect both the mother and the baby, and it is therefore strongly recommended. |
format | Online Article Text |
id | pubmed-9859768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98597682023-01-23 Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system Corsi Decenti, Edoardo Salvatore, Michele Antonio Mandolini, Donatella Donati, Serena Clin Microbiol Infect Original Article OBJECTIVES: Evidence on the effects of the SARS-CoV-2 Omicron variant on vaccinated and unvaccinated pregnant women is sparse. This study aimed to compare maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy, according to their vaccine protection. METHODS: This national prospective cohort study enrolled pregnant women with a positive SARS-CoV-2 nasopharyngeal swab within 7 days of hospital admission between 1 January and 31 May, 2022. Women who received at least one dose of vaccine during pregnancy and those who completed the vaccine cycle with the first booster were considered protected against moderate or severe COVID-19 (MSCD). A multivariable logistic regression model evaluated the association between vaccine protection and disease severity. Maternal age, educational level, citizenship, area of birth, previous comorbidities, and obesity were analysed as potential risk factors. RESULTS: MSCD was rare (41/2147, 1.9%; 95% CI, 1.4–2.6), and the odds of developing it were significantly higher among unprotected women (OR, 2.78; 95% CI, 1.39–5.57). Compared with protected women (n = 1069), the unprotected (n = 1078) were more often younger, with lower educational degrees, and foreigners. A higher probability of MSCD was found among women with previous comorbidities (OR, 2.86; 95% CI, 1.34–6.12) and those born in Asian countries (OR, 3.05; 95% CI, 1.23–7.56). The percentage of preterm birth was higher among women with MSCD compared with milder cases (32.0% [8/25] versus 8.4% [161/1917], p < 0.001) as well as the percentage of caesarean section (52.0% [13/25] versus 31.6% [606/1919], p 0.029). DISCUSSION: Although severe maternal and perinatal outcomes were rare, their prevalence was significantly higher among women without vaccine protection. Vaccination during pregnancy has the potential to protect both the mother and the baby, and it is therefore strongly recommended. European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-06 2023-01-21 /pmc/articles/PMC9859768/ /pubmed/36693525 http://dx.doi.org/10.1016/j.cmi.2023.01.013 Text en © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Corsi Decenti, Edoardo Salvatore, Michele Antonio Mandolini, Donatella Donati, Serena Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system |
title | Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system |
title_full | Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system |
title_fullStr | Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system |
title_full_unstemmed | Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system |
title_short | Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system |
title_sort | vaccination against sars-cov-2 in pregnancy during the omicron wave: the prospective cohort study of the italian obstetric surveillance system |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859768/ https://www.ncbi.nlm.nih.gov/pubmed/36693525 http://dx.doi.org/10.1016/j.cmi.2023.01.013 |
work_keys_str_mv | AT corsidecentiedoardo vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem AT salvatoremicheleantonio vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem AT mandolinidonatella vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem AT donatiserena vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem AT vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem |